S. 5243 Green Advocacy Position: Strong Opposition
The Cannabinoid Safety and Regulation Act (S. 5243) is a federal power grab that threatens to dismantle the American hemp industry under the guise of “safety.” By granting the FDA unchecked authority to ban cannabinoids at will and imposing impossible “total THC” standards, this bill would do similar damage as the passed bill with section 781, which is set to destroy 95% of the hemp industry starting November 2026. Green Advocacy strongly opposes this bill on nearly every point.
Summary
The Cannabinoid Safety and Regulation Act (S. 5243) is a federal bill that seeks to establish a comprehensive regulatory framework for hemp-derived cannabinoid products under the Food and Drug Administration (FDA). While the bill is framed as a way to “clean up” the market, it introduces significant federal restrictions, including a national age limit of 21 for purchase and strict potency caps of 5 mg of THC per serving and 50 mg per package for all hemp products.
By amending the Federal Food, Drug, and Cosmetic Act, the bill would create a new Center for Cannabinoid Products within the FDA to oversee manufacturing, testing, and labeling standards.
S. 5243 was introduced in the U.S. Senate on September 25, 2024, by Senator Ron Wyden (D-OR) and co-sponsored by Senator Jeff Merkley (D-OR). It has been referred to the Senate Committee on Health, Education, Labor, and Pensions (HELP), where it is currently awaiting further consideration.
Status
S. 5243 is currently at the Introduced stage in the U.S. Senate. As of early January 2026, it has not yet received a committee vote, a floor vote, or a companion bill in the House of Representatives.
Where the bill is now
Status on the official tracker: “Introduced,” which is the initial phase of the legislative process.
Introduced & Referred: The bill was introduced on September 25, 2024, and was immediately referred to the Senate Committee on Health, Education, Labor, and Pensions (HELP).
Activity: There has been no recorded movement—such as subcommittee hearings, markups, or votes—since its initial referral. It remains pending in committee.
Sponsorship and support
Primary Sponsor: Senator Ron Wyden (D-OR).
Cosponsors: The bill currently has one cosponsor, Senator Jeff Merkley (D-OR).
Industry Support/Opposition: While some trade groups like the U.S. Hemp Roundtable initially engaged with the bill to seek a “regulatory path,” many stakeholders in the broader hemp industry oppose it due to the restrictive 5 mg THC cap per serving, which they argue would be catastrophic for existing businesses.